Liberty Leaf to Acquire Nova Mentis Biotech Corp. – Liberty Leaf Augments Portfolio with Entrance into the Emerging Psilocybin Therapy Market

– Liberty Leaf Holdings Ltd. (CSE: LIB) (FSE: HN3P) (OTCPK: LIBFF) (“LIB” or the “Company”) is pleased to announce that it has entered into an agreement (the “Agreement”) with Nova Mentis Biotech Corp. (“NOVA”), pursuant to which LIB will acquire, by way of share exchange, 100 per cent of all of the issued and outstanding securitiesContinue reading “Liberty Leaf to Acquire Nova Mentis Biotech Corp. – Liberty Leaf Augments Portfolio with Entrance into the Emerging Psilocybin Therapy Market”